Skip to content
  • Sunday, 26 July 2026
  • 2:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties
Pharmaceutical R&D

The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties

Teuku Ryan Jul 20, 2026 0

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha Jun 20, 2026 0

In recent years, the pharmaceutical industry has witnessed a dramatic acceleration in the adoption of New Approach Methodologies (NAMs) for…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 31, 2026 0

The rapid acceleration in the adoption of New Approach Methodologies (NAMs) for drug safety testing, often perceived as a sudden…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 21, 2026 0

The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 14, 2026 0

In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 7, 2026 0

The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…

Read More
Pharmaceutical R&D

The Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug Evaluation

Teuku Ryan May 3, 2026 0

The advent of the Joint Clinical Assessment (JCA) process in the European Union, designed to harmonize the clinical evaluation of…

Read More
Clinical Diagnostics & Pathology

Breath-Based VOC Analysis Emerges as a Rapid, Non-Invasive Frontier for Gut Microbiome Assessment and Early Disease Detection

Reynand Amr Wu Apr 15, 2026 0

A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…

Read More
Clinical Diagnostics & Pathology

Breath-based VOC Analysis Offers Faster, Non-invasive Assessment of Gut Microbiome Health and Earlier Disease Detection

Reynand Amr Wu Apr 6, 2026 0

A groundbreaking study conducted by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…

Read More
Clinical Diagnostics & Pathology

New digital assessment helps lab leaders identify systemic safety gaps before serious injuries and fatalities occur.

Reynand Amr Wu Mar 20, 2026 0

The National Safety Council (NSC), a leading advocate for workplace safety, has introduced a groundbreaking digital assessment tool designed to…

Read More
UCSF Researchers Identify FTL1 Protein as Primary Driver of Hippocampal Aging and Memory Loss in Landmark StudyUS Government Assumes Full Cost of Weight Loss Drugs for Medicare Beneficiaries Through Extended GLP-1 Bridge Program Amidst Insurer HesitationIcy Environments May Have Catalyzed the Emergence of Life Through Freeze-Thaw Cycles, New Research SuggestsLilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ